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The Importance of Innovation to the U.S. in the World
Competitive Context
Paul F. Oreffice*

It is appropriate that I am in Cleveland, Ohio to speak about innovation,
because without Cleveland the Dow Chemical Company would not exist. Dow was started because Dr. Herbert Dow, while at Case Institute
of Technology, discovered a new process to extract bromine from salt
brine. He went to Michigan because there are oceans of salt brine
trapped underground in Michigan, and he tapped those like you tap oil
with wells. After several business failures, the Dow Chemical Company
was created in 1897, with money and technology from Cleveland.
The world's technological advances in the last fifty years are truly
mind-boggling. They are certainly beyond my imagination. I remember
when I first landed in the United States in 1940. One of the first things I
did was to go to the World's Fair with my family. At the World's Fair in
1940 we saw a little flickering round screen called "tele-vision." We all
agreed it would never make it. It was the consensus of the day that this
thing, technologically, was too difficult to perfect to a point where it
would become a commercial reality. When we first started talking about
sending a man to the moon, the great problem of the day was not how to
get him up there, but rather how to get him back. How would we ever
get enough fuel up there to start the booster rockets from the moon? So
the advances we have seen were beyond the imagination of most people,
and it took the inventive spirit of a few individuals to really make them
succeed.
Innovation is a way of life. You never think about the advances in
medicine like organ transplants, laser surgery, heart bypass operations
and microsurgery. Some new drugs improve our lifestyle, others are lifesaving. In this century, life expectancy has gone from thirty-eight to seventy-six years. The advances are tremendous. The United States has
always been strong technologically and we are still the world leader. A
great number of innovations have come from the United States. Our research expenditures are very high and will continue, but there are some
problems.
I think innovation is being threatened in a very pernicious way by a
good set of principles gone haywire - our legal system. Imagine the
mad chemist who starts with a small experiment in a glass tube and
winds up with foam and smoke all over the lab. That as much as any* Chairman of the Board, The Dow Chemical Company.
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thing reminds me of what has happened. Our founding fathers presented
us with probably the best set of laws in the world, all nicely contained in
that test tube. But successive additions to the test tube by judges and
others with their own agendas have made the system into a monster that
is overrunning the laboratory, and the direct result is a scary reduction in
innovation in many fields.
Everything in life entails some risk, but the safest road is usually to
repeat what has been done before. Innovation, on the other hand, always
entails a risk. The more forward-looking the innovation, the greater the
risk.
Legislators would like us to have a risk-free society. Legislators do
not want a fault-based system, but simply believe that when someone is
injured, someone else should pay, regardless of fault. If all these people
had set out to purposely slow down innovation in this country, they
could not have done a better job of it. I don't believe the purpose was to
damage innovation, but damage it they did. They certainly haven't given
us a safer world. As a matter of fact, they have given us quite the contrary. More litigation is keeping safer and better products from the
market.
I do not want to give you a litany of examples, but I do want to give
you a few examples, because I think they make some important points.
In the last five years, over one-third of all U.S. corporations have discontinued product lines because of liability concerns. What is worse, more
than one-third admit to deciding against the introduction of new products for the same reason.
The implications are staggering, especially when one looks at the
pharmaceutical field. The story of vaccines has been well documented.
Only two major companies, Merck and Lederle, are still investing in vaccine research. That's down from sixteen companies twenty years ago.
For most vaccines we are down to one producer. The price, in this decade alone, has gone up as much as one hundredfold, all because of potential liability. For the diphtheria vaccine that sells for twelve dollars, the
cost of liability is between seven and eleven dollars per dose.
Vaccines are by no means the only example. Our own pharmaceutical company, Merrill-Dow, has discontinued any product that is used by
pregnant women, and so have many others. We have discontinued the
existing products and all research. In doing this we have denied doctors
some very useful products, but the legal and insurance costs were just too
high to continue.
We all know of the examples companies and institutions have been
willing to talk about. What we don't know is how many simply pulled
their resources from this or that field or just stopped researching and
didn't say anything, like the company that discovered a substitute for
asbestos, better and safer, but decided not to market it because they were
too afraid of the liability.
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If that isn't worrisome enough, consider this. Lab work is disappearing from U.S. schools because of the liability crisis. Many school
systems have given up physics and chemistry experiments that require
heat such as the Bunsen burner because they cannot get insurance coverage. Where are our scientists and innovators of the future going to learn?
None of these are good trends. All of them hurt innovation.
Before you think that I am just a prophet of gloom, let me quickly
add that The Dow Chemical Company will spend more than $850 million on research and development this year. We are innovators. We believe in taking risks. We believe in discovering and manufacturing new
products. We believe in technology. Some of The Dow Chemical Company's better known discoveries include Styrofoam, Saran, extracting
magnesium from sea water, Seldane - an allergy product that doesn't
cause drowsiness or other side-effects, Dursban - a tremendously effective insecticide that is relatively safe to the environment, and several new
plastics. There is a broad spectrum of products with a myriad of
applications.
Most of our major technical breakthroughs have been made in the
United States, but U.S. competitiveness is constantly being put to the
test. We sell the same products inside the United States as outside, yet
Dow has 55% of its sales outside of the United States. In 1987, the last
year for which I have the statistics, Dow was sued 1663 times, seven
abroad and all of the rest in the United States. The extra cost in our U.S.
business over our foreign business in that same year was between $120
million and $150 million. This is the extra cost of insurance, the legal
cost of settlements, and so forth. But despite all the problems, U.S. inventiveness has done very well.
When we look at the state of innovation in the United States, we
must conclude that we are still the most inventive country in the world.
However, it is also fair to say that our lead has shrunk. Of the top forty
corporations receiving U.S. patents in 1988, twenty-six were U.S.-based
companies, eleven were Japanese, and three were European. Significantly, for someone in my business, fifteen of the twenty-six were chemical companies.
Inventing is not enough. It is just as important to carry the invention to market in a practical fashion and to improve the manufacturing
technology. It is in these phases that the United States has sometimes
fallen behind other countries in the world. For instance, how many remember that videotape recorders, currently made only in Japan and Korea, are a U.S. invention? There are many other examples where.
something invented in the United States was developed by others. The
Japanese have been particularly adept at taking someone else's basic idea
and making it a commercial success through improvements, quality control and great attention to detail.
When it comes to manufacturing technology, U.S. companies in the
chemical industry have probably done the best job in retaining techno-
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logical leadership through constant innovation. The primary reason why
the U.S. chemical industry has had a positive trade balance is that we are
technologically the best in the world. Others are good, but we are right
up there. I am pleased to say that Dow is in the lead. I think we are the
best at designing, building and operating basic chemical and plastic
plants.
The creation of our "rust belt" came about in great part because our
industry became complacent and forgot that the worst axiom in business
is, "If it ain't broke, don't fix it." In practical terms, it is essential to
innovate because someone else is probably gaining on you. The example
most often cited in our country is the steel industry, which continued to
use old methods when new technologies were being developed abroad.
Taking invention, development and manufacturing technology together one must conclude that the United States has been a world leader
in innovation. But the real question is whether we will continue to be. If
my overall conclusion is that the state of U.S. innovation is quite good,
why am I so worried?
I have already mentioned the problems brought about by our liability explosion, but they are not the sole reason for a decline in U.S. innovation. This country is the only country in the world that continues to
reduce incentives to research at almost every tax modification. In fact,
the 1986 Tax Act actually encourages U.S. firms to do research abroad.
The whole regulatory system is set up so that the safe thing for the bureaucracy to do is slow down the process of innovation. The ability to
protect our intellectual property in many parts of the world is constantly
being put to the test. Without this protection we cannot afford the massive research and development investments that are needed.
So, the bottom line is that while the state of U.S. innovation is still
good, we are in for some rude surprises unless some important changes
are made. First among these are some major reforms in our tort liability
system. Some of these changes are desperately needed. What progress
has been made has occurred very slowly, and mostly at the state level.
Almost nothing has happened at the federal level.
What are some of the steps needed to help restore innovation to its
former level? First, we need to do away with strict liability and return to
the negligence standard. In just the last six to ten years we have changed
from a standard based on whether or not companies and their employees
used reasonable care to a strict liability system which is generally hostile
to innovation and change. Second, we need to do away with joint and
several liability. The deep-pocket theory has created a tremendous problem for innovation. Third, we need to do away with "junk science." We
need to accept what the body of scientists says and not listen to extremes
at either end of the spectrum. Fourth, we need to restore the authority of
the regulatory agencies, for instance, the Food and Drug Administration
("FDA"). If a drug has gone through the FDA process, has been approved by the authorities and reasonable care has been shown, that
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should be an acceptable defense to a product liability claim. Finally, we
need to make it more expensive to sue. It is just too easy to bring suit
when the plaintiff does not have to pay a defendant company's legal
costs. This has resulted in "settlement blackmail," the knowledge on the
part of the plaintiff's lawyers that it is just too expensive and time consuming for companies to defend these lawsuits. Companies are willing to
pay something just to get out of the lawsuit.
Now, how are we doing on tort reform? As I mentioned before, at
the state level we have seen some progress. Not as much progress as is
needed, but progress always spawns more progress. Five years ago tort
reform on the federal level died within days of being proposed. Last year
a bill advanced almost to completion in the House of Representatives.
This year we are already seeing people like Senator Biden introducing a
new bill, and the House is hard at work on another version. Nothing has
resulted yet, but a lot is happening. I have no real hope that we will see a
federal bill this year or next, but I think the efforts to resolve the problem
are becoming more focused.
In conclusion, over the last century U.S. entrepreneurship and inventiveness have been unique in the world. The distortion in our legal
system and the litigious society which that has created are like a cancer
eating away at the U.S. ability to innovate. We all need to work toward
making major changes in the system if we are to once again be the leaders
in the world of innovation.

